Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Bausch + Lomb (NYSE: BLCO) announced that Chairman and CEO Brent Saunders, CFO Sam Eldessouky, and CMO & Head of R&D Yehia Hashad, MD will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch + Lomb website: http://ir.bausch.com/investors/events-presentations.
About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.
© 2026 Bausch + Lomb.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251223765061/en/
Media Contact:
Chris Clark
chris.clark@bausch.com
(848) 360-1100
Investor Contact:
George Gadkowski
george.gadkowski@bausch.com
(877) 354-3705 (toll free)
Source: Bausch + Lomb Corporation